Internal Medicine
Omicron Variant: Videos with opinions on the subject.
28 Nov, 2021 | 21:33h | UTC- Omicron: What we know so far about the new COVID-19 variant | DW News
- OMG Omicron? | A Doctor Explains, LIVE – ZDoggMD
Too early to tell, but preliminary information from doctors in South Africa suggests the new Covid variant Omicron may be associated with less severe disease.
28 Nov, 2021 | 21:35h | UTC- The Omicron Variant: What Matters Most Is… – by Dr David L. Katz
- New Covid Variant Omicron: South African medical association says Omicron variant causes ‘mild disease’ – Times of India
- Video: Omicron symptoms mild so far, says South African doctor who spotted it – BBC
- South African doctor who raised alarm about omicron variant says symptoms are ‘unusual but mild’ – The Telegraph
Screening for Lung Cancer: CHEST Guideline and Expert Panel Report.
28 Nov, 2021 | 21:22h | UTCExecutive Summary: Screening for Lung Cancer: Chest Guideline and Expert Panel Report
Full Guideline: Screening for Lung Cancer: CHEST Guideline and Expert Panel Report
News Release: CHEST releases expert guidelines for lung cancer screening – Elsevier
Related:
Commentary on Twitter
CHEST Guidelines and Expert Panel Report contains 16 evidence-based recommendations for the benefits, harms, and implementation of low-dose chest computed tomography (CT) screening. https://t.co/4mvjEOftQl #CHESTOnc #CHESTGuidelines #LungCancerAwarenessMonth pic.twitter.com/uyh9Pf0s5s
— CHEST® Journal (@journal_CHEST) November 23, 2021
M-A: Association of Glucagon-like Peptide 1 Analogs and agonists administered for obesity with weight loss and adverse events.
28 Nov, 2021 | 21:09h | UTC
Fatigue as the chief complaint: epidemiology, causes, diagnosis, and treatment.
28 Nov, 2021 | 21:05h | UTC
2021 DORIS definition of remission in SLE: final recommendations from an international task force.
26 Nov, 2021 | 10:01h | UTC
Systematic Review: Quantifying anticholinergic burden and sedative load in older adults with polypharmacy.
26 Nov, 2021 | 09:58h | UTC
Commentary on Twitter
Systematic review of risk scales for anticholinergic burden and sedative overload – authors developed a comprehensive table on anticholinergics & sedatives (with potency). Check Table 2 and Table S2 (supplementary) for usable info to guide decision-making!https://t.co/JYaSuOeHqv
— deprescribing.org (@deprescribing) November 25, 2021
Systematic Review: Reducing medication errors for adults in hospital settings.
26 Nov, 2021 | 09:56h | UTCReducing medication errors for adults in hospital settings – Cochrane Library
Commentary on Twitter
Reducing medication errors for adults in hospital.
New review of 65 studies involving over 100,000 participantshttps://t.co/yxGKxumZP0#MedicationErrors #PatientSafety@aciapponi pic.twitter.com/4lb9NNxtpo— Cochrane EPOC (@CochraneEPOC) November 25, 2021
Systematic Review: Insufficient evidence to recommend Omega‐3 fatty acids for depression in adults.
26 Nov, 2021 | 09:54h | UTCOmega‐3 fatty acids for depression in adults – Cochrane Library
Commentary on Twitter
'At present, we do not have sufficient high‐certainty evidence to determine the effects of Omega‐3 fatty acids as a treatment for depression in adults' – updated @Cochrane_CCMD systematic review https://t.co/Bg9VNMnyGx
— The Cochrane Library (@CochraneLibrary) November 25, 2021
Opinion | Things we do for no reason: prescribing appetite stimulants to hospitalized older adults with unintentional weight loss.
26 Nov, 2021 | 09:44h | UTC
Heavily mutated coronavirus variant puts scientists on alert – “Researchers are racing to determine whether a fast-spreading variant in South Africa poses a threat to COVID vaccines’ effectiveness”.
26 Nov, 2021 | 08:42h | UTCHeavily mutated coronavirus variant puts scientists on alert – Nature
See also:
Covid: New heavily mutated variant B.1.1.529 in South Africa raises concern – BBC
Scientists warn of new Covid variant with high number of mutations – The Guardian
South Africa detects new COVID variant with many mutations – MedicalXpress
Related commentary on Twitter (thread – click for more)
THREAD on the new variant B.1.1.529 summarising what is known from the excellent South African Ministry of Health meeting earlier today
TLDR: So much uncertain but what *is* known is extremely worrying & (in my opinion) we should revise red list immediately.
This is why: 1/16
— Prof. Christina Pagel – @chrischirp.bsky.social (@chrischirp) November 25, 2021
Review: Prevention and management of thrombosis in hospitalized patients with COVID-19 pneumonia.
26 Nov, 2021 | 08:44h | UTC
[Preprint] Serological responses to COVID-19 booster vaccine in England.
26 Nov, 2021 | 08:34h | UTCSerological responses to COVID-19 booster vaccine in England – medRxiv
Commentary from the author on Twitter (thread – click for more)
1/ Our preprint on #SARSCoV2 antibody responses in UK adults receiving a #COVID19 vaccine booster with the Pfizer vaccine at least 6 months after primary immunisation with Pfizer or AZ vaccine, which was given at an extended interval (8-12 wks) … 🧵
— Shamez Ladhani (@ShamezLadhani) November 25, 2021
A population-based cohort study in Qatar showed reinfections had 90% lower odds of resulting in hospitalization or death than primary infections.
25 Nov, 2021 | 10:46h | UTC
Guideline for the laboratory diagnosis of iron deficiency in adults (excluding pregnancy) and children.
25 Nov, 2021 | 10:31h | UTC
Systematic Review: Macrolides versus placebo for chronic asthma.
25 Nov, 2021 | 10:14h | UTCMacrolides versus placebo for chronic asthma – Cochrane Library
Commentary on Twitter
Graphical abstract for #Cochrane Review on #Macrolides versus placebo for chronic #asthma Full review here https://t.co/SrHacxWoNr pic.twitter.com/0YCd9Xptlz
— CochraneAirways (@CochraneAirways) November 24, 2021
Diets for weight management in adults with type 2 diabetes: an umbrella review of published meta-analyses and systematic review of trials of diets for diabetes remission – “Published meta-analyses of hypocaloric diets for weight management in people with type 2 diabetes do not support any particular macronutrient profile or style over others”.
25 Nov, 2021 | 10:19h | UTC
Commentary on Twitter
https://twitter.com/DiabetologiaJnl/status/1461773268231147521
M-A: Incidence, prevalence and determinants of discomfort in inflammatory bowel disease.
25 Nov, 2021 | 09:54h | UTC
Cohort study found the risk of myocardial infarction may be best predicted by the number of apolipoprotein B containing lipoproteins.
24 Nov, 2021 | 08:41h | UTCAssociation of Apolipoprotein B–Containing Lipoproteins and Risk of Myocardial Infarction in Individuals With and Without Atherosclerosis: Distinguishing Between Particle Concentration, Type, and Content – JAMA Cardiology (link to abstract – $ for full-text)
Commentaries:
ApoB Gains Ground as Best Lipid Predictor of MI Risk – TCTMD
Study finds risk of MI best captured by number of apolipoprotein B lipoproteins – MedicalResearch
Commentary on Twitter
Study from @marstonMD @TIMIStudyGroup et al found lipid-associated risk for myocardial infarction is best captured by the number of apoB-containing lipoproteins, independent from lipid content (cholesterol or TG) or type of lipoprotein (LDL or TG-rich) https://t.co/UBby6mtj6e
— JAMA Cardiology (@JAMACardio) November 13, 2021
Review: COVID-19-associated Invasive Fungal Infection.
24 Nov, 2021 | 08:48h | UTCCOVID-19-associated Invasive Fungal Infection – Open Forum Infectious Diseases
Related:
Consensus Guideline: Defining and managing COVID-19-associated pulmonary aspergillosis
Bacterial and fungal superinfections in critically ill patients with COVID-19
Invasive Fungal Disease complicating COVID-19: when it rains it pours
A national strategy to diagnose COVID-19 associated invasive fungal disease in the ICU
Epidemiology of invasive pulmonary aspergillosis among COVID-19 intubated patients
Commentary on Twitter
A new article in OFID reviews COVID-19-associated fungal infections and addresses gaps in knowledge relating to the epidemiology, diagnosis and management of these infections: https://t.co/JIkkW70zHI#IDSAJournals #OpenForumInfectDis @PaulSaxMD @DrJLi @jobadd @DrPappasID pic.twitter.com/bPmFdKkjmb
— IDSA (@IDSAInfo) November 21, 2021
AGA Clinical practice update on management of chronic gastrointestinal pain in disorders of gut–brain interaction.
24 Nov, 2021 | 08:42h | UTC
Viewpoint: The growing phenomenon of “virtual-first” primary care.
24 Nov, 2021 | 08:39h | UTCThe Growing Phenomenon of “Virtual-First” Primary Care – JAMA (free for a limited period)
We expected people with asthma to fare worse during COVID. Turns out they’ve had a break.
24 Nov, 2021 | 08:44h | UTC
Safety analysis of RCTs showed Alzheimer’s drug Aducanumab caused brain swelling in 35% of patients, and 26.0% experienced associated symptoms (e.g., headache, confusion, dizziness, and nausea).
24 Nov, 2021 | 08:35h | UTCCommentary: Biogen Alzheimer’s drug shows brain swelling in 35% of patients – MedicalXpress
Commentary on Twitter
Amyloid-related imaging abnormalities occurred in ~ 40% of participants in the phase 3 studies of aducanumab. Approximately one-quarter of patients with amyloid-related imaging abnormalities experience symptoms https://t.co/TnUPXT686l
— JAMA Neurology (@JAMANeuro) November 22, 2021
Three Neurologic Societies, Including the AAN, Issue Strong Position Statement on Aducanumab.
24 Nov, 2021 | 08:36h | UTCRelated:
Editorial: Aducanumab for Alzheimer’s disease?
FDA approvement of Alzheimer’s drug sparks controversy among doctors.
Commentary on Twitter
Decisions With Patients and Families Regarding #Aducanumab in Alzheimer Disease, With Recommendations for Consent—Read the full AAN @AANMember Position Statement: https://t.co/ckoIVRi4DE #Neurology pic.twitter.com/q8TSU67zm9
— Neurology Journal (@GreenJournal) November 19, 2021


